{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T07:38:13Z","timestamp":1792827493441,"version":"4.5.0"},"reference-count":89,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T00:00:00Z","timestamp":1685491200000},"content-version":"am","delay-in-days":303,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Emergency Medicine"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.ajem.2022.05.042","type":"journal-article","created":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T01:57:02Z","timestamp":1653962222000},"page":"135-140","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["High risk and low prevalence diseases: Giant cell arteritis"],"prefix":"10.1016","volume":"58","author":[{"given":"Aaron","family":"Lacy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Koyfman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brit","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ajem.2022.05.042_bb0005","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s13075-021-02450-w","article-title":"A meta-analysis of the epidemiology of giant cell arteritis across time and space","volume":"23","author":"Li","year":"2021","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"10.1016\/j.ajem.2022.05.042_bb0010","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s11916-018-0655-y","article-title":"Giant cell arteritis: practical pearls and updates","volume":"22","author":"Pradeep","year":"2018","journal-title":"Curr Pain Headache Rep"},{"issue":"7","key":"10.1016\/j.ajem.2022.05.042_bb0015","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1080\/1744666X.2018.1485491","article-title":"Current and emerging diagnosis tools and therapeutics for giant cell arteritis","volume":"14","author":"Gonz\u00e1lez-Gay","year":"2018","journal-title":"Expert Rev Clin Immunol"},{"issue":"3","key":"10.1016\/j.ajem.2022.05.042_bb0020","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/rheumatology\/keg116","article-title":"Giant cell arteritis: epidemiological clues to its pathogenesis and an update on its treatment","volume":"42","author":"Nordborg","year":"2003","journal-title":"Rheumatology."},{"issue":"2","key":"10.1016\/j.ajem.2022.05.042_bb0025","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s11940-020-00660-2","article-title":"One giant step for giant cell arteritis: updates in diagnosis and treatment","volume":"23","author":"Dinkin","year":"2021","journal-title":"Curr Treat Options Neurol"},{"issue":"2","key":"10.1016\/j.ajem.2022.05.042_bb0030","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s00296-018-4157-3","article-title":"Diagnosis and differential diagnosis of large-vessel vasculitides","volume":"39","author":"Keser","year":"2019","journal-title":"Rheumatol Int"},{"issue":"7","key":"10.1016\/j.ajem.2022.05.042_bb0035","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1080\/08916930903002495","article-title":"Vascular damage in giant cell arteritis","volume":"42","author":"Piggott","year":"2009","journal-title":"Autoimmunity."},{"issue":"2","key":"10.1016\/j.ajem.2022.05.042_bb0040","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1084\/jem.20030850","article-title":"Activation of arterial wall dendritic cells and breakdown of self-tolerance in giant cell arteritis","volume":"199","author":"Ma-Krupa","year":"2004","journal-title":"J Exp Med"},{"issue":"4","key":"10.1016\/j.ajem.2022.05.042_bb0045","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.jbspin.2016.07.005","article-title":"Pro-inflammatory and anti-inflammatory T cells in giant cell arteritis","volume":"84","author":"Watanabe","year":"2017","journal-title":"Joint Bone Spine"},{"issue":"5","key":"10.1016\/j.ajem.2022.05.042_bb0050","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1172\/JCI84181","article-title":"NADPH oxidase deficiency underlies dysfunction of aged CD8+ Tregs","volume":"126","author":"Wen","year":"2016","journal-title":"J Clin Invest"},{"issue":"8","key":"10.1016\/j.ajem.2022.05.042_bb0055","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.autrev.2017.05.014","article-title":"Recent advances in our understanding of giant cell arteritis pathogenesis","volume":"16","author":"Samson","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.ajem.2022.05.042_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/EB.S170388","article-title":"Giant cell arteritis: early diagnosis is key","volume":"11","author":"Baig","year":"2019","journal-title":"Eye Brain"},{"key":"10.1016\/j.ajem.2022.05.042_bb0065","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2147\/TCRM.S13088","article-title":"Optimal management of giant cell arteritis and polymyalgia rheumatica","volume":"8","author":"Charlton","year":"2012","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.ajem.2022.05.042_bb0070","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1136\/ard.2009.111005","article-title":"Increase in age at onset of giant cell arteritis: a population-based study","volume":"69","author":"Kermani","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.ajem.2022.05.042_bb0075","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/01.md.0000145366.40805.f8","article-title":"Aortic aneurysm and dissection in patients with biopsy-proven giant cell arteritis from northwestern Spain: a population-based study","volume":"83","author":"Gonzalez-Gay","year":"2004","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1016\/j.ajem.2022.05.042_bb0080","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/jama.287.1.92","article-title":"Does this patient have temporal arteritis?","volume":"287","author":"Smetana","year":"2002","journal-title":"JAMA."},{"issue":"3","key":"10.1016\/j.ajem.2022.05.042_bb0085","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/art.23315","article-title":"Development of aortic aneurysm\/dilatation during the followup of patients with giant cell arteritis: a cross-sectional screening of fifty four prospectively followed patients","volume":"59","author":"Garcia-Martinez","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ajem.2022.05.042_bb0090","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1056\/NEJMra011913","article-title":"Polymyalgia rheumatica and giant-cell arteritis","volume":"347","author":"Salvarani","year":"2002","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ajem.2022.05.042_bb0095","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s12916-017-0871-z","article-title":"Diagnostic delay for giant cell arteritis\u2014a systematic review and meta-analysis","volume":"15","author":"Prior","year":"2017","journal-title":"BMC Med"},{"issue":"5","key":"10.1016\/j.ajem.2022.05.042_bb0100","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1001\/archneur.1972.00490170010003","article-title":"Arteries of the head and neck in giant cell arteritis. A pathological study to show the pattern of arterial involvement","volume":"27","author":"Wilkinson","year":"1972","journal-title":"Arch Neurol"},{"issue":"3","key":"10.1016\/j.ajem.2022.05.042_bb0105","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.semarthrit.2016.07.005","article-title":"Cerebrovascular accident in patients with giant cell arteritis: a systematic review and meta-analysis of cohort studies","volume":"46","author":"Ungprasert","year":"2016","journal-title":"Semin Arthritis Rheum"},{"issue":"10","key":"10.1016\/j.ajem.2022.05.042_bb0110","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1002\/anr.1780321017","article-title":"Mental status abnormalities in temporal arteritis: a treatable cause of dementia in the elderly","volume":"32","author":"Pascuzzi","year":"1989","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.ajem.2022.05.042_bb0115","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1136\/jnnp.51.12.1594","article-title":"Involvement of smell and taste in giant cell arteritis","volume":"51","author":"Schon","year":"1988","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"10","key":"10.1016\/j.ajem.2022.05.042_bb0120","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1212\/WNL.30.10.1054","article-title":"Ophthalmoplegia, ptosis, and miosis in temporal arteritis","volume":"30","author":"Dimant","year":"1980","journal-title":"Neurology."},{"issue":"2","key":"10.1016\/j.ajem.2022.05.042_bb0125","first-page":"91","article-title":"Bilateral sixth nerve pareses with temporal arteritis and diabetes","volume":"6","author":"Jay","year":"1986","journal-title":"J Clin Neuroophthalmol"},{"issue":"11","key":"10.1016\/j.ajem.2022.05.042_bb0130","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1016\/j.ophtha.2013.04.009","article-title":"Isolated third, fourth, and sixth cranial nerve palsies from presumed microvascular versus other causes: a prospective study","volume":"120","author":"Tamhankar","year":"2013","journal-title":"Ophthalmology."},{"issue":"12","key":"10.1016\/j.ajem.2022.05.042_bb0135","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.1002\/art.11353","article-title":"Incidence and predictors of large-artery complication (aortic aneurysm, aortic dissection, and\/or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50 years","volume":"48","author":"Nuenninghoff","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.ajem.2022.05.042_bb0140","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1136\/annrheumdis-2011-200865","article-title":"Large vessel involvement in biopsy-proven giant cell arteritis: prospective study in 40 newly diagnosed patients using CT angiography","volume":"71","author":"Prieto-Gonzalez","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.ajem.2022.05.042_bb0145","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1136\/annrheumdis-2011-200795","article-title":"Distribution of arterial lesions in Takayasu\u2019s arteritis and giant cell arteritis","volume":"71","author":"Grayson","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.ajem.2022.05.042_bb0150","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3899\/jrheum.140188","article-title":"Visual manifestations in giant cell arteritis: trend over 5 decades in a population-based cohort","volume":"42","author":"Singh","year":"2015","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.ajem.2022.05.042_bb0155","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/WNO.0000000000000538","article-title":"Is routine imaging of the aorta warranted in patients with giant cell arteritis?","volume":"37","author":"Chen","year":"2017","journal-title":"J Neuroophthalmol"},{"issue":"8","key":"10.1016\/j.ajem.2022.05.042_bb0160","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/art.1780330810","article-title":"The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis","volume":"33","author":"Hunder","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ajem.2022.05.042_bb0165","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.survophthal.2005.06.011","article-title":"Giant cell (temporal) arteritis: an overview and update","volume":"50","author":"Rahman","year":"2005","journal-title":"Surv Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajem.2022.05.042_bb0170","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/WNO.0000000000000234","article-title":"Diagnostic algorithm for patients with suspected giant cell arteritis","volume":"35","author":"El-Dairi","year":"2015","journal-title":"J Neuroophthalmol"},{"issue":"1","key":"10.1016\/j.ajem.2022.05.042_bb0175","first-page":"1","article-title":"2016 ACR revised criteria for early diagnosis of giant cell (temporal) arteritis","volume":"3","author":"Salehi-Abrari","year":"2016","journal-title":"Autoimmune Diseases and Therapeutic Approaches Open Access"},{"key":"10.1016\/j.ajem.2022.05.042_bb0180","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ijso.2017.09.003","article-title":"The 2016 revised ACR criteria for diagnosis of giant cell arteritis - our case series: can this avoid unnecessary temporal artery biopsies?","volume":"9","author":"Sait","year":"2017","journal-title":"Int J Surgery Open"},{"key":"10.1016\/j.ajem.2022.05.042_bb0185","first-page":"506","article-title":"The spectrum of giant cell arteritis and polymyalgia rheumatica: revisiting the concept of the disease","volume":"56","author":"Dejaco","year":"2017","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.ajem.2022.05.042_bb0190","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/rheumatology\/keab353","article-title":"Evaluation of revised classification criteria for giant cell arteritis and its clinical phenotypes","volume":"61","author":"Wiberg","year":"2022","journal-title":"Rheumatology."},{"issue":"1","key":"10.1016\/j.ajem.2022.05.042_bb0195","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1056\/NEJMcp1214825","article-title":"Clinical practice. Giant-cell arteritis and polymyalgia rheumatica","volume":"371","author":"Weyand","year":"2014","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.ajem.2022.05.042_bb0200","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/rheumatology\/kez672","article-title":"British Society for Rheumatology guidelines on diagnosis and treatment of giant cell arteritis","volume":"59","author":"Mackie","year":"2020","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"10.1016\/j.ajem.2022.05.042_bb0205","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1001\/jamainternmed.2020.3050","article-title":"Diagnostic accuracy of symptoms, physical signs and laboratory tests for giant cell arteritis","volume":"180","author":"van der Geest","year":"2020","journal-title":"JAMA Intern Med"},{"issue":"1","key":"10.1016\/j.ajem.2022.05.042_bb0210","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1055\/s-0038-1677023","article-title":"Evaluation and management of the emergency department headache","volume":"39","author":"Filler","year":"2019","journal-title":"Semin Neurol"},{"issue":"Suppl. 1","key":"10.1016\/j.ajem.2022.05.042_bb0215","article-title":"Binocular sight loss: uncommon, yet a devastating complication of GCA","volume":"3","author":"Borukhson","year":"2019","journal-title":"Rheumatol Adv Pract"},{"issue":"2","key":"10.1016\/j.ajem.2022.05.042_bb0220","doi-asserted-by":"crossref","first-page":"ii63","DOI":"10.1093\/rheumatology\/kex428","article-title":"Ophthalmic manifestations of giant cell arteritis","volume":"57","author":"Vodopivec","year":"2018","journal-title":"Rheumatology."},{"issue":"18","key":"10.1016\/j.ajem.2022.05.042_bb0225","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1056\/NEJMc1511420","article-title":"Chewing gum test for jaw claudication in giant-cell arteritis","volume":"374","author":"Kuo","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajem.2022.05.042_bb0230","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/00005792-200301000-00002","article-title":"Audiovestibular manifestations in giant cell arteritis: a prospective study","volume":"82","author":"Amor-Dorado","year":"2003","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ajem.2022.05.042_bb0235","first-page":"688","article-title":"Visual improvement with corticosteroid therapy in giant cell arteritis","volume":"80","author":"Hayreh","year":"2002","journal-title":"Report of a large study and review of literature Acta Ophthalmol Scand"},{"issue":"6","key":"10.1016\/j.ajem.2022.05.042_bb0240","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/art.1780230605","article-title":"Presentation of occult giant cell arteritis","volume":"23","author":"Healey","year":"1980","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.ajem.2022.05.042_bb0245","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1002\/art.1780241113","article-title":"Giant cell arteritis (temporal arteritis) presenting as fever of undetermined origin","volume":"24","author":"Calamia","year":"1981","journal-title":"Arthritis Rheum"},{"issue":"10","key":"10.1016\/j.ajem.2022.05.042_bb0250","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2147\/OPTH.S94971","article-title":"Update on the evaluation of transient vision loss","author":"Pula","year":"2016","journal-title":"Clin Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajem.2022.05.042_bb0255","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1212\/CPJ.0b013e31824cb084","article-title":"Approach to the patient with acute monocular visual loss","volume":"2","author":"Prasad","year":"2012","journal-title":"Neurol Clin Pract"},{"issue":"11","key":"10.1016\/j.ajem.2022.05.042_bb0260","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/S0161-6420(94)31102-X","article-title":"Visual morbidity in giant cell arteritis. Clinical characteristics and prognosis for vision","volume":"101","author":"Liu","year":"1994","journal-title":"Ophthalmology."},{"issue":"6","key":"10.1016\/j.ajem.2022.05.042_bb0265","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.semarthrit.2011.10.005","article-title":"Utility of erythrocyte sedimentation rate and C-reactive protein for the diagnosis of giant cell arteritis","volume":"41","author":"Kermani","year":"2012","journal-title":"Semin Arthritis Rheum"},{"issue":"10","key":"10.1016\/j.ajem.2022.05.042_bb0270","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1016\/j.ophtha.2006.05.020","article-title":"Prevalence of a normal C-reactive protein with an elevated erythrocyte sedimentation rate in biopsy-proven giant cell arteritis","volume":"113","author":"Parikh","year":"2006","journal-title":"Ophthalmology."},{"issue":"3","key":"10.1016\/j.ajem.2022.05.042_bb0275","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1177\/112067210401400310","article-title":"Role of thrombocytosis in diagnosis of giant cell arteritis and differentiation of arteritic from non-arteritic anterior ischemic optic neuropathy","volume":"14","author":"Costello","year":"2004","journal-title":"Eur J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajem.2022.05.042_bb0280","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0002-9394(14)70123-0","article-title":"Giant cell arteritis: validity and reliability of various diagnostic criteria","volume":"123","author":"Hayreh","year":"1997","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajem.2022.05.042_bb0285","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.annemergmed.2015.02.020","article-title":"Giant cell arteritis: read the fine print!","volume":"65","author":"Jhun","year":"2015","journal-title":"Ann Emerg Med"},{"issue":"6","key":"10.1016\/j.ajem.2022.05.042_bb0290","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.ophtha.2010.10.002","article-title":"Giant cell arteritis: laboratory predictors of a positive temporal artery biopsy","volume":"118","author":"Walvick","year":"2011","journal-title":"Ophthalmology."},{"key":"10.1016\/j.ajem.2022.05.042_bb0295","first-page":"119","article-title":"Which clinical features and lab findings increase the likelihood of temporal arteritis?","volume":"57","author":"Ellen","year":"2008","journal-title":"J Fam Pract"},{"issue":"21","key":"10.1016\/j.ajem.2022.05.042_bb0300","first-page":"376","article-title":"The diagnosis and treatment of giant cell arteritis","volume":"110","author":"Ness","year":"2013","journal-title":"Dtsch Arztebl Int"},{"key":"10.1016\/j.ajem.2022.05.042_bb0305","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.1002\/art.22163","article-title":"Treatment of giant cell arteritis using induction therapy with high-dose glucocorticoids: a double-blind, placebo-controlled, randomized prospective clinical trial","volume":"54","author":"Mazlumzadeh","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ajem.2022.05.042_bb0310","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1136\/annrheumdis-2019-215672","article-title":"Update of the EULAR recommendations for the management of large vessel vasculitis","volume":"79","author":"Hellmich","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ajem.2022.05.042_bb0315","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S0161-6420(93)31608-8","article-title":"Visual prognosis in giant cell arteritis","volume":"100","author":"Aiello","year":"1993","journal-title":"Ophthalmology."},{"issue":"4","key":"10.1016\/j.ajem.2022.05.042_bb0320","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1056\/NEJMoa1613849","article-title":"Trial of tocilizumab in Giant-cell arteritis","volume":"377","author":"Stone","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajem.2022.05.042_bb0325","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1002\/art.22754","article-title":"Adjunctive methotrexate for treatment of giant cell arteritis: an individual patient data meta-analysis","volume":"56","author":"Mahr","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ajem.2022.05.042_bb0330","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1136\/ard.45.2.136","article-title":"Azathioprine in giant cell arteritis\/polymyalgia rheumatica: a double-blind study","volume":"45","author":"De Silva","year":"1986","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ajem.2022.05.042_bb0335","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/art.21699","article-title":"Repetitive 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients","volume":"55","author":"Blockmans","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ajem.2022.05.042_bb0340","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/rheumatology\/kem322","article-title":"Ultrasound of proximal upper extremity arteries to increase the diagnostic yield in large-vessel giant cell arteritis","volume":"47","author":"Schmidt","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ajem.2022.05.042_bb0345","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jbspin.2010.09.013","article-title":"Aortic involvement in giant cell arteritis: current data","volume":"78","author":"Bossert","year":"2011","journal-title":"Jt Bone Spine"},{"issue":"30","key":"10.1016\/j.ajem.2022.05.042_bb0350","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000004146","article-title":"Positron emission tomography and computed tomography angiography for the diagnosis of giant cell arteritis: A real-life prospective study","volume":"95","author":"Lariviere","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1016\/j.ajem.2022.05.042_bb0355","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1136\/annrheumdis-2012-202145","article-title":"Should I send my patient with previous giant cell arteritis for imaging of the thoracic aorta? A systematic literature review and meta-analysis","volume":"73","author":"Mackie","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.ajem.2022.05.042_bb0360","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1755-3768.2008.01314.x","article-title":"Giant cell arteritis: an updated review","volume":"87","author":"Kawasaki","year":"2009","journal-title":"Acta Ophthalmol"},{"issue":"19","key":"10.1016\/j.ajem.2022.05.042_bb0365","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1056\/NEJM199711063371902","article-title":"Color duplex ultrasonography in the diagnosis of temporal arteritis","volume":"337","author":"Schmidt","year":"1997","journal-title":"N Engl J Med"},{"issue":"suppl_2","key":"10.1016\/j.ajem.2022.05.042_bb0370","doi-asserted-by":"crossref","first-page":"ii22","DOI":"10.1093\/rheumatology\/kex461","article-title":"Ultrasound in the diagnosis and management of giant cell arteritis","volume":"57","author":"Schmidt","year":"2018","journal-title":"Rheumatology."},{"issue":"4","key":"10.1016\/j.ajem.2022.05.042_bb0375","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1055\/s-2008-1041094","article-title":"Neurologic complications of giant cell (temporal) arteritis","volume":"14","author":"Caselli","year":"1994","journal-title":"Semin Neurol"},{"issue":"Suppl. 2","key":"10.1016\/j.ajem.2022.05.042_bb0380","doi-asserted-by":"crossref","first-page":"i2","DOI":"10.1093\/rheumatology\/keu184","article-title":"3. Pathogenesis of giant cell arteritis","volume":"53","author":"Cid","year":"2014","journal-title":"Rheumatology."},{"issue":"3","key":"10.1016\/j.ajem.2022.05.042_bb0385","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1093\/rheumatology\/keh058","article-title":"Tissue production of pro-inflammatory cytokines (IL-1beta, TNFalpha and IL-6) correlates with the intensity of the systemic inflammatory response and with corticosteroid requirements in giant-cell arteritis","volume":"43","author":"Hern\u00e1ndez-Rodr\u00edguez","year":"2004","journal-title":"Rheumatology."},{"key":"10.1016\/j.ajem.2022.05.042_bb0390","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ajo.2018.05.031","article-title":"Pathologic markers determining prognosis in patients with treated or healing giant cell arteritis","volume":"193","author":"Sultan","year":"2018","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"10.1016\/j.ajem.2022.05.042_bb0395","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/nrrheum.2017.98","article-title":"Visual loss and other cranial ischaemic complications in giant cell arteritis","volume":"13","author":"Soriano","year":"2017","journal-title":"Nat Rev Rheumatol"},{"issue":"6","key":"10.1016\/j.ajem.2022.05.042_bb0400","first-page":"1026","article-title":"Giant cell arteritis of the tongue presenting as macroglossia","volume":"15","author":"Helfrich","year":"1988","journal-title":"J Rheumatol"},{"issue":"4","key":"10.1016\/j.ajem.2022.05.042_bb0405","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.jaad.2008.11.913","article-title":"Scalp necrosis in giant cell arteritis: case report and review of the relevance of this cutaneous sign of large-vessel vasculitis","volume":"61","author":"Tsianakas","year":"2009","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl. 1","key":"10.1016\/j.ajem.2022.05.042_bb0410","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1007\/s10067-009-1141-z","article-title":"Tongue necrosis as first symptom of giant cell arteritis (GCA)","volume":"28","author":"Brodmann","year":"2009","journal-title":"Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.ajem.2022.05.042_bb0415","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1308\/003588411X12851639107476","article-title":"The role of temporal artery biopsies in giant cell arteritis","volume":"93","author":"Davies","year":"2011","journal-title":"Ann R Coll Surg Engl"},{"issue":"5","key":"10.1016\/j.ajem.2022.05.042_bb0420","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1093\/rheumatology\/kez385","article-title":"Sensitivity of temporal artery biopsy in the diagnosis of giant cell arteritis: a systematic literature review and meta-analysis","volume":"59","author":"Rubenstein","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ajem.2022.05.042_bb0425","doi-asserted-by":"crossref","first-page":"359","DOI":"10.7326\/0003-4819-142-5-200503010-00011","article-title":"Meta-analysis: test performance of ultrasonography for giant-cell arteritis","volume":"142","author":"Karassa","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ajem.2022.05.042_bb0430","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2474-11-44","article-title":"The diagnostic value of ultrasonography-derived edema of the temporal artery wall in giant cell arteritis: a second meta-analysis","volume":"11","author":"Arida","year":"2010","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.ajem.2022.05.042_bb0435","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2017-000612","article-title":"Imaging in diagnosis, outcome prediction and monitoring of large vessel vasculitis: a systematic literature review and meta-analysis informing the EULAR recommendations","volume":"4","author":"Duftner","year":"2018","journal-title":"RMD Open"},{"key":"10.1016\/j.ajem.2022.05.042_bb0440","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.autrev.2018.07.012","article-title":"Diagnostic performance of temporal artery ultrasound for the diagnosis of giant cell arteritis: a systematic review and meta-analysis of the literature","volume":"18","author":"Rinagel","year":"2019","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.ajem.2022.05.042_bb0445","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta20900","article-title":"The role of ultrasound compared to biopsy of temporal arteries in the diagnosis and treatment of giant cell arteritis (TABUL): a diagnostic accuracy and cost-effectiveness study","volume":"20","author":"Luqmani","year":"2016","journal-title":"Health Technol Assess"}],"container-title":["The American Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675722003515?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675722003515?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:02:30Z","timestamp":1760025750000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735675722003515"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":89,"alternative-id":["S0735675722003515"],"URL":"https:\/\/doi.org\/10.1016\/j.ajem.2022.05.042","relation":{},"ISSN":["0735-6757"],"issn-type":[{"value":"0735-6757","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High risk and low prevalence diseases: Giant cell arteritis","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajem.2022.05.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}